Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.45 |
| ▸ | HPGD | P15428 | 3/20 | 0.45 |
| ▸ | HTR3E | A5X5Y0 | 2/20 | 0.45 |
| ▸ | HTR3B | O95264 | 2/20 | 0.45 |
| ▸ | HTR3A | P46098 | 2/20 | 0.45 |
| ▸ | HTR3D | Q70Z44 | 2/20 | 0.45 |
| ▸ | HTR3C | Q8WXA8 | 2/20 | 0.45 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | TTR | P02766 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16795954 | 1.00 | ALDH1A1 (0.45) | ALDH1A1HPGDHTR3EHTR3BHTR3A | |
| SCHEMBL18085326 | 0.91 | ALDH1A1 (0.40) | ALDH1A1HPGDHTR3EHTR3BHTR3A | |
| SCHEMBL668348 | 0.83 | TRPV4 (0.48) | ALDH1A1HTR3EHTR3BHTR3AHTR3D | |
| SCHEMBL29636402 | 0.77 | TRPV4 (0.55) | ALDH1A1HTR3EHTR3BHTR3AHTR3D | |
| SCHEMBL2127233 | 0.77 | TRPV4 (0.55) | ALDH1A1HTR3EHTR3BHTR3AHTR3D | |
| SCHEMBL9715823 | 0.76 | ACHE (0.60) | ALDH1A1HPGDMEN1KMT2ACYP3A4 | |
| SCHEMBL9715789 | 0.76 | CA12 (0.60) | ALDH1A1MEN1KMT2ACYP1A2CYP3A4 | |
| SCHEMBL10382796 | 0.75 | ALDH1A1 (0.41) | ALDH1A1HPGDMEN1KMT2ACYP2D6 | |
| SCHEMBL196490 | 0.75 | TTR (0.62) | ALDH1A1HPGDTRPV4MEN1KMT2A | |
| SCHEMBL7699644 | 0.75 | ALDH1A1 (0.56) | ALDH1A1HPGDTRPV4MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230331643-A1 | BUTADIENE TELOMERIZATION CATALYST PREPARATION AND USE THEREOF | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-10-19 | — | — | US | disclosed |
| US-11713286-B2 | Butadiene telomerization catalyst preparation and use thereof | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-08-01 | — | — | US | disclosed |
| US-20220213006-A1 | BUTADIENE TELOMERIZATION CATALYST PREPARATION AND USE THEREOF | DOW GLOBAL TECHNOLOGIES LLC (US) | 2022-07-07 | — | — | US | disclosed |
| US-11312670-B2 | Butadiene telomerization catalyst and preparation thereof | DOW GLOBAL TECHNOLOGIES LLC (US) | 2022-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11312670-B2 | Butadiene telomerization catalyst and preparation thereof | TELO2, TERT, POT1 | ALDH1A1 824/4885HPGD 1233/4885HTR3E 2370/4885 |
| US-11713286-B2 | Butadiene telomerization catalyst preparation and use thereof | TELO2, TERT, TPR | ALDH1A1 954/4885HPGD 1254/4885HTR3E 2291/4885 |
| US-20230331643-A1 | BUTADIENE TELOMERIZATION CATALYST PREPARATION AND USE THEREOF | TELO2, TERT, TPR | ALDH1A1 954/4885HPGD 1254/4885HTR3E 2291/4885 |
| US-20220213006-A1 | BUTADIENE TELOMERIZATION CATALYST PREPARATION AND USE THEREOF | TELO2, TERT, TPR | ALDH1A1 954/4885HPGD 1254/4885HTR3E 2291/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.